Species : |
Human |
Source : |
E.coli |
Tag : |
Non |
Description : |
At least 23 different variants of IFNA1 areknown. The individual proteins have molecular masses between 19-26 kDa andconsist of proteins with lengths of 156-166 and 172 amino acids. All IFNA1subtypes possess a common conserved sequence region between amino acidpositions 115-151 while the amino-terminal ends are variable. Many IFNA1subtypes differ in their sequences at only one or two positions. Naturallyoccurring variants also include proteins truncated by 10 amino acids at thecarboxy-terminal end. |
Form : |
Lyophilized from a0.2 um filtered solution in PBS, pH 7.4. |
Purity : |
> 96% by SDS-PAGEand HPLC analyses. |
Endotoxin Level : |
Less than 1EU/mL ofrHuIFN-α1b as determined by LAL method. |
Biological Activity : |
Fully biologicallyactive when compared to standard. The specific activity as determined in aviral resistance assay was found to be no less than 1.0 x 108IU/mg. |
Reconstitution : |
We recommend thatthis vial be briefly centrifuged prior to opening to bring the contents tothe bottom. Reconstitute in sterile distilled water or aqueous buffer to aconcentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned intoworking aliquots and stored at ≤20°C. Further dilutions should be made inappropriate buffered solutions. |
Storage : |
This lyophilizedpreparation is stable at 2-8°C, but should be kept at -20°C for long termstorage, preferably desiccated. Upon reconstitution, the preparation is stablefor up to one week at 2-8°C. For maximal stability, apportion thereconstituted preparation into working aliquots and store at -20°C to -80°C.Avoid repeated freeze/thaw cycles. |
OfficialSymbol : |
IFNA1 |